PATENT CLAIM ANALYSIS

Application Number: 16303975
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-07
Patent Classification: ["514", "004900"]

Abstract:
The present invention relates to a peptide compound that may be useful in the treatment or prophylaxis of obesity, diabetes and the like. More specifically, the present invention relates to a peptide compound represented by the formula (I): P 1 -Tyr-Aib-Glu-Gly-Thr-α-MePhe-Thr-Ser-Asp-Lys(-Gly-Gly-Gly-Gly-R A10 )-A11-A12-Aib-Leu-A15-Lys-Gln-A18-Gln-Iva-Glu-Phe-Val-Arg-His-Leu-Leu-Asn-Lys-Aib-Thr-Arg-Gln-Arg-A35-NH 2  wherein each symbol is as defined in the specification, and the treatment or prophylaxis of obesity, diabetes and the like using the peptide compound.

Claim (Index 3):
The peptide according to  claim 1  or a salt thereof, wherein R A10  is Pal.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 98.0
- Lexical Diversity: 1.66667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15941030', '14780579', '14287514', '15300069', '14125061']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8565406575148589
- 35 USC 102 Novelty (BERT): 0.6245200283226503
- Combined Prediction Score: 0.8333385945956381
- Mean Citation Score: 618.618672
- Max Citation Score: 664.82526
- Similarity Product: 491.79539033688064

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test